HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double-blind comparative trial of dihydroxydibutylether in patients with cholesterol gallstones.

Abstract
In a double-blind crossover design we compared dihydroxydibutylether (DHBE) with placebo in ten patients with cholesterol gallstones. The results showed that DHBE reduced (p less than 0.01) the bile saturation index (SI). The bile lipid composition demonstrated that the reduced SI was due to a decrease (p less than 0.01) in the molar percentage of cholesterol. There was no significant modification in biliary acid and phospholipid molar percentage.
AuthorsC Sama, A Petronelli, M Malavolti, G Mastroroberto, E Roda
JournalInternational journal of clinical pharmacology, therapy, and toxicology (Int J Clin Pharmacol Ther Toxicol) Vol. 21 Issue 2 Pg. 95-7 (Feb 1983) ISSN: 0174-4879 [Print] Germany
PMID6341262 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Cholagogues and Choleretics
  • Ethers
  • Cholesterol
  • 4,4'-oxydi-2-butanol
Topics
  • Adult
  • Bile (metabolism)
  • Cholagogues and Choleretics (therapeutic use)
  • Cholelithiasis (drug therapy)
  • Cholesterol (metabolism)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Ethers (therapeutic use)
  • Female
  • Humans
  • Lipid Metabolism
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: